The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
A Comparison of Beclomethasone, Salmeterol, and Placebo in Children with Asthma
Open accessAbstract
BACKGROUND: An inhaled glucocorticoid is currently the medication of choice for long-term control of persistent asthma in children. The role of long-acting beta2-adrenergic-receptor agonists, such as salmeterol, needs to be defined. METHODS: We conducted a randomized, double-blind, placebo-controlled, parallel-group, one-year study of 241 children (mean [+/-SD] age, 9.3+/-2.4 years) with clinically stable asthma and less than one month of prior glucocorticoid use. We compared inhaled beclomethasone dipropionate (200 microg twice daily) with salmeterol xinafoate (50 microg twice daily) and placebo (lactose). The primary outcome measure, airway responsiveness (as assessed with a methacholine challenge) was evaluated before treatment; after 3, 6, 9, and 12 months of treatment (12 and 36 hours after study medications had been withheld); and 2 weeks after the end of treatment. Spirometry, symptoms, use of rescue medication (200 microg of albuterol inhaled as needed), and adverse effects were also assessed. RESULTS: During months 1 through 12 overall, beclomethasone was associated with significantly less airway hyperresponsiveness than salmeterol (P= 0.003) or placebo (P<0.001). This effect was lost two weeks after treatment had been stopped. As compared with placebo, beclomethasone was associated with less variability between morning and evening in the peak expiratory flow (P=0.002), as was salmeterol (P=0.02). Beclomethasone was also associated with a reduced need for albuterol as rescue therapy (P<0.001) and fewer withdrawals because of asthma exacerbations (P=0.03), but salmeterol was not (P=0.09 and 0.55, respectively). During months 1 through 12, linear growth was 3.96 cm in the children receiving beclomethasone, as compared with 5.40 cm in the salmeterol group (P=0.004) and 5.04 cm in the placebo group (P=0.018). Height was not measured after treatment ended. CONCLUSIONS: Beclomethasone was effective in reducing airway hyperresponsiveness and in controlling symptoms of asthma, but it was associated with decreased linear growth. Salmeterol was not as effective as beclomethasone in reducing airway hyperresponsiveness or in controlling symptoms; however, it was an effective bronchodilator and was not associated with rebound airway hyperresponsiveness, masking of symptoms, or adverse effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · Technometrics · doi:10.1198/tech.2005.s303 · Cited by 17,923
Applied Regression Analysis (2nd ed).
de Carvalho, J. F., Draper, N. R., & Smith, H. (1981) · Journal of the American Statistical Association · doi:10.2307/2287608 · Cited by 3,044
Changes in the normal maximal expiratory flow-volume curve with growth and aging.
Knudson, R. J., Lebowitz, M. D., Holberg, C. J., & Burrows, B. A. (1983) · PubMed · doi:10.1164/arrd.1983.127.6.725 · Cited by 1,907
Bronchial reactivity to inhaled histamine: a method and clinical survey
COCKCROFT, D. W., KILLIAN, D. N., MELLON, J. J. A., & HARGREAVE, F. E. (1977) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1977.tb01448.x · Cited by 1,840
Analysis of Repeated Measures.
Elashoff, J. D., Crowder, M. J., & Hand, D. J. (1991) · Journal of the American Statistical Association · doi:10.2307/2290432 · Cited by 930
Agertoft, L., & Pedersen, S. (1994) · Respiratory Medicine · doi:10.1016/0954-6111(94)90044-2 · Cited by 756
Inhaled Steroids and the Risk of Hospitalization for Asthma
Donahue, J. G. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540350037030 · Cited by 509
Van Essen-Zandvliet, E. E., Hughes, M. D., Waalkens, H. J., Duiverman, E. J., Pocock, S. J., Kerrebijn, K. F., & The Dutch Chronic Non-Specific Lung Disease Study Group (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/146.3.547 · Cited by 456
Third International Pediatric Consensus statement on the management of childhood asthma
Warner, J. O., Naspitz, C. K., & Cropp, G. J. A. (1998) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199801)25:1<1::aid-ppul1>3.0.co;2-s · Cited by 389
A meta-analysis of the effect of oral and inhaled corticosteroids on growth
Allen, D. B., Mullen, M., & Mullen, B. (1994) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(94)70043-5 · Cited by 300
Cited by
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
PAUWELS, R. A. (1996) · Arerugī/Arerugi · doi:10.15036/arerugi.45.792 · Cited by 9,994
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Long-Term Effects of Budesonide or Nedocromil in Children with Asthma
(2000) · New England Journal of Medicine · doi:10.1056/nejm200010123431501 · Cited by 1,365
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report
Bacharier, L. B., Boner, A., Carlsen, K. ‐., Eigenmann, P. A., Frischer, T., Götz, M., Helms, P. J., Hunt, J., Liu, A., Papadopoulos, N., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01586.x · Cited by 640
Self-citation
Metadata
- Authors
- Simons, F. E. R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1997-12-04
- Volume
- 337
- Issue
- 23
- Pages
- 1659-1665
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2337667511
- Cited by
- 326
- References
- 25
- FWCI
- 20.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Comparison of Beclomethasone, Salmeterol, and Placebo in Children with Asthma. https://app.cochat.ai/papers/10.1056/nejm199712043372304
- The paper
- Simons, F. E. R. (1997). A Comparison of Beclomethasone, Salmeterol, and Placebo in Children with Asthma. New England Journal of Medicine. https://doi.org/10.1056/nejm199712043372304
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.